Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Degarelix in Men With LUTS Associated With BPH
NCT00947882Phase 2Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Aug 2009
- Primary completion
- Mar 2011
- Modality
- Peptides, Small Molecules
- Countries
- 6
01
Overview
A Phase 2 trial of degarelix in benign prostatic hyperplasia (BPH), sponsored by Ferring Pharmaceuticals. Started Aug 2009; status: completed.
02
Drugs
degarelix
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00947882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00947882.